Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso
Status:
Terminated
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
The investigators' hypothesis is that pretreating patients with COPD with inhaled
treprostinil prior to pulmonary rehabilitation sessions will result in improved exercise
tolerance during sessions. This in turn will lead to an increased response to pulmonary
rehabilitation, resulting in improved exercise tolerance and quality of life.